«‹1234567»Seite
9 articles with references, page 1 of 9

Review article

The Indications for Liver Biopsy

Dtsch Arztebl Int 2012; 109(27-28): 477-83; DOI: 10.3238/arztebl.2012.0477

Tannapfel, A; Dienes, H; Lohse, A W

1. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD: Liver biopsy. Hepatology 2009; 49: 1017–44. CrossRef MEDLINE
2.Lohse AW. Rolls Royce for everybody? Diagnosing liver disease by mini-laparoscopy. J Hepatol 2011; 54: 584–5. CrossRef MEDLINE
3.Cornberg M, Protzer U, Petersen J, et al.: Prophylaxis, diagnosis and therapy of hepatitis B virus infection – the German guideline. Z Gastroenterol 2011; 49: 871–930. CrossRef MEDLINE
4.Sarrazin C, Berg T, Ross RS, et al.: Update der S3-Leitlinie Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion, AWMF-Register-Nr.: 021/012. Z Gastroenterol 2010; 48: 289–351. CrossRef MEDLINE
5.Lohse AW, Mieli-Vergani G: Autoimmune hepatitis. J Hepatol 2011; 55: 171–82. CrossRef MEDLINE
6.Wiegard C, Schramm C, Lohse AW: Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future. Semin Liver Dis 2009; 29: 254–61. CrossRef MEDLINE
7.Lüth S, Weiler-Normann C, Schramm C, Lohse AW: Autoimmune liver diseases. Internist (Berl) 2009; 50: 310–7.
8.Helmreich-Becker I, Schirmacher P, Denzer U, et al.: Minilaparoscopy in the diagnosis of cirrhosis: superiority in patients with Child-Pugh A and macronodular disease. Endoscopy 2003; 35: 55–60. CrossRef MEDLINE
9.Chalasani N, Bjornsson E: Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 2010; 138: 2246–59. CrossRef MEDLINE PubMed Central
10.Dienes HP, Drebber U: Pathology of immune-mediated liver injury. Dig Dis 2010; 28: 57–62. CrossRef MEDLINE
11.Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E: International Autoimmune Hepatitis Group overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011; 54: 374–85. CrossRef MEDLINE
12.Lewin M, Vilgrain V, Ozenne V, et al.: Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study. Hepatology 2009; 50: 528–37. CrossRef MEDLINE
13.Culver EL, Chapman RW: Systematic review: management options for primary sclerosing cholangitis and its variant forms – IgG4-associated cholangitis and overlap with autoimmune hepatitis. Aliment Pharmacol Ther 2011; 33: 1273–91. CrossRef MEDLINE
14.Tannapfel A, Denk H, Dienes HP, et al.: Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch 2011; 458: 511–23. CrossRef MEDLINE
15.Musso G, Gambino R, Cassader M, Pagano G: Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43: 617–49. CrossRef MEDLINE
16.Pietrangelo A: Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment. Gastroenterology 2010; 139: 393–408. CrossRef MEDLINE
17.Tannapfel A, Reinacher-Schick A: Chemotherapy associated hepatotoxicity in the treatment of advanced colorectal cancer (CRC). Z Gastroenterol 2008; 46: 435–40. CrossRef MEDLINE
18.Miraglia R, Luca A, Gruttadauria S, Minervini MI, Vizzini G, Arcadipane A, Gridelli B. Contribution of transjugular liver biopsy in patients with the clinical presentation of acute liver failure. Cardiovasc Intervent Radiol 2006; 29: 1008–10. CrossRef MEDLINE
19.Silva MA, Hegab B, Hyde C, Guo B, Buckels JA, Mirza DF: Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 2008; 57: 1592–6. CrossRef MEDLINE
20.Tischoff I, Tannapfel A: Hepatocellular carcinoma and cholangiocarcinoma – different prognosis, pathogenesis and therapy. Zentralbl Chir 2007; 132: 300–5. CrossRef MEDLINE
21.Bosman FT, Carneiro F, Hruban RH, Theise ND (eds.): WHO classification of tumors of the digestive system. Lyon: IARC 2010.
22.Cho SW, Marsh JW, Steel J, et al.: Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol 2008; 15: 2795–803. CrossRef MEDLINE
23.Stölzel U, Tannapfel A: Indications for liver biopsy in liver tumors. Zentralbl Chir 2000; 125: 606–9. MEDLINE
24.Bruix J, Sherman M: Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020–2. CrossRef MEDLINE PubMed Central
e1.Ewe K: Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981; 26: 388–93. CrossRef MEDLINE
e2.Caldwell S, Northup PG: Bleeding complication with liver biopsy: is it predictable? Clin Gastroenterol Hepatol 2010; 8: 826–9. CrossRef MEDLINE
e3.Castera L, Forns X, Alberti A: Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48: 835–47. CrossRef MEDLINE
e4. Glaser J, Pausch J: Perkutane Leberbiopsie. In: Empfehlungen der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten. Berlin: DGVS 2003. Available from: www.dgvs.de/media/6.1.Leberbiopsie.pdf.
e5.Denzer U, Lohse AW: Laparoskopie. In: Empfehlungen der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten. Berlin: DGVS 2003. Available from: www.dgvs.de/media/6.2.Laparoskopie.pdf.